The analysis of interleukin-6 in patients with systemic IgG4-related plasmacytic syndrome - Expansion of SIPS to the territory of Castleman's disease

Rheumatology

Volumn 48, Issue 7, 2009, Pages 860-862

  Yamamoto, Motohisa ^a   Takahashi, Hiroki ^a   Hasebe, Kohhei ^b   Suzuki, Chisako ^a   Naishiro, Yasuyoshi ^a   Hayashi, Toshiaki ^a   Yamamoto, Hiroyuki ^a   Ishida, Tadao ^a   Shinomura, Yasuhisa ^a  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b TEINE KEIJINKAI HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; IMMUNOGLOBULIN G4; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 6;

ADULT; AUTOIMMUNE DISEASE; CASE REPORT; CELL INFILTRATION; CLINICAL FEATURE; CYTOKINE PRODUCTION; FIBROSIS; HUMAN; HYPOCOMPLEMENTEMIA; IMMUNOGLOBULIN BLOOD LEVEL; INTERSTITIAL NEPHRITIS; LETTER; LYMPH NODE BIOPSY; LYMPH NODE HYPERPLASIA; MALE; PAROTID ENLARGEMENT; PLASMA CELL; PRIORITY JOURNAL; SUBMANDIBULAR GLAND; SYSTEMIC DISEASE; SYSTEMIC IMMUNOGLOBULIN PLASMACYTIC SYNDROME;

AGED; GIANT LYMPH NODE HYPERPLASIA; GRANULOMA, PLASMA CELL; HUMANS; IMMUNOGLOBULIN G; INTERLEUKIN-6; LYMPHATIC DISEASES; MALE; MIDDLE AGED; PLASMA CELLS; SYNDROME;

EID: 67650085140     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kep098     Document Type: Letter

References (16)

1. Yamamoto M, Takahashi H, Ohara M et al. A new conceptualization for Mikulicz's disease as an IgG4-related plasmacytic disease. Mod Rheumatol 2006;16:335-40.
2. Masaki Y, Dong L, Kurose N et al. Proposal for a new clinical entitiy, IgG4-positive multi-organ lymphoproliferative syndrome: analysis of 64 cases of IgG4-related disorders. Ann Rheum Dis. Advance Access published August 13, 2008, doi:10.1136/ard.2008.089169.
3. Yamamoto M, Harada S, Ohara M et al. Beneficial effects of steroid therapy for Mikulicz's disease. Rheumatology 2005;44:1322-3.
4. Tsubota K, Fujita H, Tsuzaka K, Takeuchi T. Mikulicz's disease and Sjögren's syndrome. Invest Ophthalmol Vis Sci 2000;41:1666-73.
5. Castleman B, Iverson L, Menendez VP. Localized mediastinal lymph-node hyperplasia resembling thymoma. Cancer 1956;9:822-30.
6. Frøkjaer Thomsen O, Ladefoged J. Castleman's disease with renal infiltration by polyclonal plasma cells. Clin Nephrol 1998;49:328-30.
7. Frizzera G. Castleman's disease and related disorders. Semin Diagn Pathol 1988;5:346-64.
8. Peterson BA, Frizzera G. Multicentric Castleman's disease. Semin Oncol 1993; 20:636-47.
9. Dispenzieri A. Castleman disease. Cancer Treat Res 2008;142:293-330.
10. Yoshizaki K, Matsuda T, Nishimoto N et al. Pathogenic significance of interleukin-6 (IL-6/BSF-2) in Castleman's disease. Blood 1989;74:1360-7.
11. Ishida F, Kitano K, Kobayashi H, Saito H, Kiyosawa K. Elevated IgG4 levels in a case with multicentric Castleman's disease. Br J Haematol 1997;99:981-2.
12. Leonard AL, Meehan SA, Ramsey D, Brown L, Sen F. Cutaneous and systemic plasmacytosis. J Am Acad Dermatol 2007;56:S38-40.
13. Uhara H, Saida T, Ikegawa S et al. Primary cutaneous plasmacytosis: Report of three cases and review of the literature. Dermatology 1994;189:251-5.
14. Watanabe S, Ohara K, Kukita A, Mori S. Systemic plasmacytosis. A syndrome of peculiar multiple skin eruptions, generalized lymphadenopathy, and polyclonal hypergammaglobulinemia. Arch Dermatol 1986;122:1314-20.
15. Yamamoto T, Soejima K, Katayama I, Nishioka K. Intralesional steroid therapy-induced reduction of plasma interleukin-6 and improvement of cutaneous plasmacytosis. Dermatology 1995;190:242-4.
16. Higashi Y, Kanekura T, Sakamoto R, Mochitomi Y, Kanzaki T. Multicentric Castleman disease with cutaneous manifestations: Report of 2 cases and comparison with systemic plasmacytosis. Dermatology 2007;214:170-3.